Gene · 5251
Papers1,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Rare and Novel PHEX Variants in X-linked Hypophosphatemia. | J Clin Endocrinol Metab | 2024 | 38722819 | PubTator, text mining | PubMed |
| Preparation and evaluation of inhalable S-allylmercapto-N-acetylcysteine and nintedanib co-loaded liposomes for pulmonary fibrosis. | Eur J Pharm Sci | 2024 | 38670294 | PubTator, text mining | PubMed |
| Spontaneous Akt2 deficiency in a colony of NOD mice exhibiting early diabetes. | Sci Rep | 2024 | 38643275 | PubTator, text mining | PubMed |
| El diálogo oculto entre el hueso y los tejidos a través del remodelado óseo. | Adv Lab Med | 2024 | 38634083 | PubTator, text mining | PubMed |
| Experience of X-linked hypophosphatemic rickets in the Gulf Cooperation Council countries: case series. | Endocrinol Diabetes Metab Case Rep | 2024 | 38614130 | PubTator, text mining | PubMed |
| Fructooligosaccharides act on the gut-bone axis to improve bone independent of Tregs and alter osteocytes in young adult C57BL/6 female mice. | JBMR Plus | 2024 | 38562914 | PubTator, text mining | PubMed |
| Characterization of Novel PHEX Variants in X-linked Hypophosphatemic Rickets and Genotype-PHEX Activity Correlation. | J Clin Endocrinol Metab | 2024 | 38442738 | PubTator, text mining | PubMed |
| Deciphering the molecular mechanism of Bu Yang Huan Wu Decoction in interference with diabetic pulmonary fibrosis via regulating oxidative stress and lipid metabolism disorder. | J Pharm Biomed Anal | 2024 | 38430615 | PubTator, text mining | PubMed |
| Familial cases with adult-onset FGF23-related hypophosphatemic osteomalacia -A PHEX 3'-UTR change as a possible cause. | Bone | 2024 | 38412893 | PubTator, text mining | PubMed |
| Real-world data of Brazilian adults with X-linked hypophosphatemia (XLH) treated with burosumab and comparison with other worldwide cohorts. | Mol Genet Genomic Med | 2024 | 38337160 | PubTator, text mining | PubMed |
| Complex intrinsic abnormalities in osteoblast lineage cells of X-linked hypophosphatemia: Analysis of human iPS cell models generated by CRISPR/Cas9-mediated gene ablation. | Bone | 2024 | 38331306 | PubTator, text mining | PubMed |
| Switching to burosumab from conventional therapy in siblings with relatively well-controlled X-linked hypophosphatemia. | Clin Pediatr Endocrinol | 2024 | 38299174 | PubTator, text mining | PubMed |
| The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities. | Genes Dis | 2024 | 38292186 | PubTator, text mining | PubMed |
| Rare Causes of Musculoskeletal Pain: Thinking beyond Common Rheumatologic Diseases. | Case Rep Rheumatol | 2024 | 38283708 | PubTator, text mining | PubMed |
| A patient-centred and multi-stakeholder co-designed observational prospective study protocol: Example of the adolescent experience of treatment for X-linked hypophosphataemia (XLH). | PLoS One | 2024 | 38241270 | PubTator, text mining | PubMed |
| SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells. | Cell Mol Biol Lett | 2024 | 38229033 | PubTator, text mining | PubMed |
| Disease Manifestations and Complications in Dutch X-Linked Hypophosphatemia Patients. | Calcif Tissue Int | 2024 | 38226986 | PubTator, text mining | PubMed |
| X-linked hypophosphatemia due to a de novo novel splice-site variant in a 7-year-old girl with scaphocephaly, Chiari syndrome type I and syringomyelia. | Bone Rep | 2024 | 38226334 | PubTator, text mining | PubMed |
| FGF23-related hypophosphatemic rickets preceding the onset of systemic lupus erythematosus: A juvenile case. | Clin Case Rep | 2024 | 38223518 | PubTator, text mining | PubMed |
| Multiple circulating forms of neprilysin detected with novel epitope-directed monoclonal antibodies. | Cell Mol Life Sci | 2024 | 38217709 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5251/papers?page=8